Key result
Endothelial lamin A/C deletion reduces median survival by ~15% and accelerates cardiovascular disease in mice.
Why the study?
The mechanisms underlying aging as a major risk factor for cardiovascular disease remain incompletely understood, prompting an investigation into age-associated changes in endothelial lamin A/C expression and the contribution of its loss to cardiovascular dysfunction and disease.
Does endothelial-specific lamin A/C deficiency impair mechanotransduction and promote vascular dysfunction, atherosclerosis, and HFpEF-like cardiac remodeling in atheroprone mice?
Does endothelial-specific lamin A/C deficiency impair mechanotransduction and promote vascular dysfunction, atherosclerosis, and HFpEF-like cardiac remodeling in atheroprone mice?
This preclinical study identifies age-dependent loss of endothelial lamin A/C as a novel driver of endothelial dysfunction, atherosclerosis, and HFpEF-like cardiac remodeling via impaired KLF2-NOS3 mechanotransduction.
Answers are grounded in this paper and cite their sources.
Endothelial lamin A/C loss may contribute to vascular aging phenotypes; leaves open its relevance and therapeutic potential in humans.
Aims: Aging is a major risk factor for cardiovascular disease, but the underlying mechanisms remain incompletely understood. Here, we investigated age-associated changes in endothelial lamin A/C expression and the contribution of endothelial lamin A/C loss to cardiovascular dysfunction and disease. Methods and Results: Aging was associated with reduced endothelial lamin A/C expression in human coronary arteries and mouse aorta and heart. We generated an inducible endothelial-specific Lmna knockout mouse model on an atheroprone Ldlr -null background ( Lmna KO iEC ), which exhibited a 14.6% reduction in median survival. Vascular and cardiac phenotypes were evaluated using vascular reactivity assays, magnetic resonance imaging, blood pressure measurements, echocardiography, histology, nitric oxide assays, and biochemical analyses. Lmna KO iEC mice exhibited increased atherosclerotic burden, impaired endothelium-dependent vasodilation, vascular hyperpermeability, arterial stiffening, and hypertension. They also displayed increased cardiac mass, elevated NT-proBNP levels, incipient myocardial fibrosis, and signs of increased cardiac filling pressures despite preserved systolic function, resembling early stages of heart failure with preserved ejection fraction (HFpEF). Cardiac proteomics revealed inflammatory, profibrotic, and metabolic remodeling, with enrichment of molecular signatures associated with human HFpEF. Mechanistically, aortic single-cell transcriptomics revealed endothelial activation and suppression of the flow-responsive KLF2-NOS3 pathway. Consistently, endothelial lamin A/C deficiency reduced aortic nitric oxide production ex vivo, while siRNA-mediated LMNA knockdown impaired shear stress-induced KLF2 and NOS3 expression in human aortic endothelial cells. Conclusion: These findings identify age-associated endothelial lamin A/C downregulation as a previously unrecognized contributor to cardiovascular aging and disease, and suggest preservation of endothelial nuclear mechanotransduction as a potential therapeutic strategy. Translational Relevance: Our findings identify age-associated endothelial lamin A/C downregulation as a previously unrecognized contributor to cardiovascular aging, linking impaired nuclear mechanotransduction to age-related endothelial dysfunction and cardiovascular pathologies, including atherosclerosis, hypertension, and cardiac alterations resembling early HFpEF. These results highlight endothelial lamin A/C and downstream flow-responsive KLF2-NOS3 signaling as potential targets for therapeutic strategies aimed at preserving endothelial function and mitigating age-related cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Lara et al. (2026) studied Cardiovascular aging, atherosclerosis, and heart failure with preserved ejection fraction (HFpEF). Endothelial-specific lamin A/C (Lmna) deletion vs. Cre-negative littermate control mice (Lmnaflox/flox Ldlr-/- Cdh5CreERT2-/-) was evaluated on Median survival (14.6% reduction in median survival). Endothelial-specific lamin A/C deletion in mice reduced median survival by 14.6% and promoted atherosclerosis, endothelial dysfunction, hypertension, and HFpEF-like cardiac remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: